---
figid: PMC7576747__12967_2020_2574_Fig3_HTML
figlink: pmc/articles/PMC7576747/figure/Fig3/
number: F3
caption: 'Intervention to reduce ROS for the prevention of CIN: evidence from in vitro,
  in vivo and clinical studies. In response to the mechanisms involved in ROS production
  in CIN, interventions to reduce ROS via complex pathways are illustrated. The MAPK
  pathway was inhibited by statins, GKT137831 and probucol. The SIRT1 pathway was
  inhibited by resveratrol. Rho/ROCK pathway was inhibited by fasudil. The Nrf-2/HO-1
  pathway was inhibited by sulforaphane and salvianolic acid B. Antioxidant agents
  reported to exert benefits in CIN prevention have also been shown in this figure.
  CIN, contrast-induced nephropathy; GLP-1, glucagon-like peptide-1; MAPK, mitogen-activated
  protein kinase; MESNA, sodium-2-mercaptoethane sulphonate; mTOR, mammalian target
  of rapamycin; Nrf-2/HO-1, nuclear factor erythroid 2-related factor 2/heme oxygenase
  1; ROCK, rho-kinase; ROS, reactive oxygen species; SIRT1, silent information regulator'
pmcid: PMC7576747
papertitle: 'Contrast-induced nephropathy and oxidative stress: mechanistic insights
  for better interventional approaches.'
reftext: Prit Kusirisin, et al. J Transl Med. 2020;18:400.
pmc_ranked_result_index: '44442'
pathway_score: 0.9478224
filename: 12967_2020_2574_Fig3_HTML.jpg
figtitle: 'Intervention to reduce ROS for the prevention of CIN: evidence from in
  vitro, in vivo and clinical studies'
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7576747__12967_2020_2574_Fig3_HTML.html
  '@type': Dataset
  description: 'Intervention to reduce ROS for the prevention of CIN: evidence from
    in vitro, in vivo and clinical studies. In response to the mechanisms involved
    in ROS production in CIN, interventions to reduce ROS via complex pathways are
    illustrated. The MAPK pathway was inhibited by statins, GKT137831 and probucol.
    The SIRT1 pathway was inhibited by resveratrol. Rho/ROCK pathway was inhibited
    by fasudil. The Nrf-2/HO-1 pathway was inhibited by sulforaphane and salvianolic
    acid B. Antioxidant agents reported to exert benefits in CIN prevention have also
    been shown in this figure. CIN, contrast-induced nephropathy; GLP-1, glucagon-like
    peptide-1; MAPK, mitogen-activated protein kinase; MESNA, sodium-2-mercaptoethane
    sulphonate; mTOR, mammalian target of rapamycin; Nrf-2/HO-1, nuclear factor erythroid
    2-related factor 2/heme oxygenase 1; ROCK, rho-kinase; ROS, reactive oxygen species;
    SIRT1, silent information regulator'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - SIRT1
  - RHOD
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - PPARGC1A
  - PPP1R12A
  - MTOR
  - oxygen
  - NQO1, GSH
  - Sulforaphane
  - Salvianolic acid B
  - Fasudil
  - Statins
  - GKT137831
  - Probucol
  - Resveratrol
  - N-acetyleysteine
  - ascorbic acid
  - paricalcitol
  - vitamin E
  - L-carnitine
  - agomelatine
  - melatonin
  - manganese superoxide
  - sodium bicarbonate
  - MESNA
  - nephropathy
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: JNK,
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK,
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK,
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (ERK,
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (ERK,
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (ERK,JNK,p38)
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: (ERK,JNK,p38)
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: (ERK,JNK,p38)
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (ERK,JNK,p38)
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (ERK,JNK,p38)
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: SIRT1
  symbol: SIRT1
  source: hgnc_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: Rho/ROCK
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: Rho/ROCKpathwayNrf-2/HO-1pathway
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: NF-kB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB,
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: (SIRT1,
  symbol: SIRT1
  source: hgnc_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: PGC-1,p53)
  symbol: PGC1
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: PGC-1,
  symbol: PGC1
  source: hgnc_alias_symbol
  hgnc_symbol: PPARGC1A
  entrez: '10891'
- word: (MYPT-1,
  symbol: MYPT1
  source: hgnc_prev_symbol
  hgnc_symbol: PPP1R12A
  entrez: '4659'
- word: (MYPT-1,NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: (MYPT-1,NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: (MYPT-1,NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: (MYPT-1,NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: (MYPT-1,NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB)
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: oxygen
  source: MESH
  identifier: D010100
- word: NQO1, GSH
  source: MESH
  identifier: C120195
- word: Sulforaphane
  source: MESH
  identifier: C016766
- word: Salvianolic acid B
  source: MESH
  identifier: C076944
- word: Fasudil
  source: MESH
  identifier: C049347
- word: Statins
  source: MESH
  identifier: D019821
- word: GKT137831
  source: MESH
  identifier: C576694
- word: Probucol
  source: MESH
  identifier: D011341
- word: Resveratrol
  source: MESH
  identifier: C059514
- word: N-acetyleysteine
  source: MESH
  identifier: D009584
- word: ascorbic acid
  source: MESH
  identifier: D001205
- word: paricalcitol
  source: MESH
  identifier: C084656
- word: vitamin E
  source: MESH
  identifier: D014810
- word: L-carnitine
  source: MESH
  identifier: D002331
- word: agomelatine
  source: MESH
  identifier: C084711
- word: melatonin
  source: MESH
  identifier: D008550
- word: manganese superoxide
  source: MESH
  identifier: D013481
- word: sodium bicarbonate
  source: MESH
  identifier: D017693
- word: MESNA
  source: MESH
  identifier: D015080
diseases:
- word: nephropathy
  source: MESH
  identifier: D007674
figid_alias: PMC7576747__F3
redirect_from: /figures/PMC7576747__F3
figtype: Figure
---
